Ardal C - Search Results

1

Mapping of available health research and development data: what's there, what's missing, and what role is there for a global observatory?

Røttingen JA, Regmi S, Eide M, Young AJ, Viergever RF, Ardal C, Guzman J, Edwards D, Matlin SA, Terry RF. Røttingen JA, et al. Among authors: ardal c. Lancet. 2013 Oct 12;382(9900):1286-307. doi: 10.1016/S0140-6736(13)61046-6. Epub 2013 May 20. Lancet. 2013. PMID: 23697824

2

Common characteristics of open source software development and applicability for drug discovery: a systematic review.

Ardal C, Alstadsæter A, Røttingen JA. Ardal C, et al. Health Res Policy Syst. 2011 Sep 28;9:36. doi: 10.1186/1478-4505-9-36. Health Res Policy Syst. 2011. PMID: 21955914 Free PMC article.

3

Open source drug discovery in practice: a case study.

Årdal C, Røttingen JA. Årdal C, et al. PLoS Negl Trop Dis. 2012;6(9):e1827. doi: 10.1371/journal.pntd.0001827. Epub 2012 Sep 20. PLoS Negl Trop Dis. 2012. PMID: 23029588 Free PMC article.

4

An open source business model for malaria.

Årdal C, Røttingen JA. Årdal C, et al. PLoS One. 2015 Feb 6;10(2):e0117150. doi: 10.1371/journal.pone.0117150. eCollection 2015. PLoS One. 2015. PMID: 25658590 Free PMC article.

5

International cooperation to improve access to and sustain effectiveness of antimicrobials.

Årdal C, Outterson K, Hoffman SJ, Ghafur A, Sharland M, Ranganathan N, Smith R, Zorzet A, Cohn J, Pittet D, Daulaire N, Morel C, Rizvi Z, Balasegaram M, Dar OA, Heymann DL, Holmes AH, Moore LS, Laxminarayan R, Mendelson M, Røttingen JA. Årdal C, et al. Lancet. 2016 Jan 16;387(10015):296-307. doi: 10.1016/S0140-6736(15)00470-5. Epub 2015 Nov 18. Lancet. 2016. PMID: 26603920 Review.

6

Financing and collaboration on research and development for nodding syndrome.

Årdal C, Røttingen JA. Årdal C, et al. Health Res Policy Syst. 2016 Mar 17;14:19. doi: 10.1186/s12961-016-0091-6. Health Res Policy Syst. 2016. PMID: 26983551 Free PMC article.

7

An antibiotic's journey from marketing authorization to use, Norway.

Årdal C, Blix HS, Plahte J, Røttingen JA. Årdal C, et al. Bull World Health Organ. 2017 Mar 1;95(3):220-226. doi: 10.2471/BLT.16.172874. Epub 2017 Jan 19. Bull World Health Organ. 2017. PMID: 28250535 Free PMC article.

8

Pull Incentives for Antibacterial Drug Development: An Analysis by the Transatlantic Task Force on Antimicrobial Resistance.

Årdal C, Røttingen JA, Opalska A, Van Hengel AJ, Larsen J. Årdal C, et al. Clin Infect Dis. 2017 Oct 15;65(8):1378-1382. doi: 10.1093/cid/cix526. Clin Infect Dis. 2017. PMID: 29017240

9

Insights into early stage of antibiotic development in small- and medium-sized enterprises: a survey of targets, costs, and durations.

Årdal C, Baraldi E, Theuretzbacher U, Outterson K, Plahte J, Ciabuschi F, Røttingen JA. Årdal C, et al. J Pharm Policy Pract. 2018 Apr 5;11:8. doi: 10.1186/s40545-018-0135-0. eCollection 2018. J Pharm Policy Pract. 2018. PMID: 29632669 Free PMC article.

10

Should Antibiotics Be Controlled Medicines? Lessons from the Controlled Drug Regimen.

Storehagen L, Aftab F, Årdal C, Savic M, Røttingen JA. Storehagen L, et al. Among authors: ardal c. J Law Med Ethics. 2018 Jun;46(1_suppl):81-94. doi: 10.1177/1073110518782919. J Law Med Ethics. 2018. PMID: 30146964

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

38 results

Search Page